Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.82 |
| ▸ | LMNA | P02545 | 1/20 | 0.82 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.82 |
| ▸ | MGAM | O43451 | 2/20 | 0.52 |
| ▸ | GAA | P10253 | 2/20 | 0.52 |
| ▸ | SI | P14410 | 2/20 | 0.52 |
| ▸ | MGAM2 | Q2M2H8 | 2/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.46 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.46 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | GLO1 | Q04760 | 1/20 | 0.41 |
| ▸ | PKM | P14618 | 2/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | CA12 | O43570 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | CA9 | Q16790 | 1/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ethyl Acetate SCHEMBL6295337 | 1.00 | ALDH1A1 (0.82) | ALDH1A1LMNAHSD17B10MGAMGAA | |
| Ethyl Acetate SCHEMBL1561858 | 0.97 | ALDH1A1 (0.78) | ALDH1A1LMNAHSD17B10MGAMGAA | |
| Ethyl Acetate SCHEMBL6728709 | 0.97 | ALDH1A1 (0.78) | ALDH1A1LMNAHSD17B10MGAMGAA | |
| Ethyl Acetate SCHEMBL8727488 | 0.92 | ALDH1A1 (0.70) | ALDH1A1LMNAHSD17B10MGAMGAA | |
| Cyclohexane SCHEMBL1831332 | 0.92 | ALDH1A1 (0.70) | ALDH1A1LMNAHSD17B10MGAMGAA | |
| Ethyl Acetate SCHEMBL1487590 | 0.91 | — | — | |
| Ethyl Acetate SCHEMBL1331990 | 0.91 | — | — | |
| Ethyl Acetate SCHEMBL28457765 | 0.91 | ALDH1A1 (1.00) | ALDH1A1LMNAHSD17B10MGAMGAA | |
| Ethyl Acetate SCHEMBL8506185 | 0.91 | ALDH1A1 (1.00) | ALDH1A1LMNAHSD17B10MGAMGAA | |
| Ethyl Acetate SCHEMBL1331901 | 0.91 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 95 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103180325-A | Method for preparing beta-artemether | SHANGHAI DESANO PHARMACEUTICALS INVEST CO LTD | 2013-06-26 | — | — | CN | claimed |
| WO-2011101861-A1 | PROCESS FOR PREPARATION OF DPP-IV INHIBITORS | MSN LABORATORIES LIMITED (IN) | 2011-08-25 | — | — | WO | claimed |
| US-4902793-A | Process for preparing 3-alkoxymethylcephalosporins | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 1990-02-20 | — | — | US | claimed |
| CN-85102995-A | 1,2,4-triazole nitrogen-alkylating method | — | 1987-04-29 | — | — | CN | claimed |
| US-12567576-B2 | Method of preparing negative electrode | LG ENERGY SOLUTION, LTD. (KR) | 2026-03-03 | — | — | US | disclosed |
| US-20260014213-A1 | BACTERIAL STRAINS FROM CLOSTRIDIA OR BACILLI AND METHODS OF TREATING OBESITY, METABOLIC SYNDROME, DIABETES AND INFLAMMATORY BOWEL DISEASE | UNIV UTAH RES FOUND (US) | 2026-01-15 | — | — | US | disclosed |
| US-12431530-B2 | Nonaqueous electrolyte secondary battery | PANASONIC INTELLECTUAL PROPERTY MANAGEMENT CO., LTD. (JP) | 2025-09-30 | — | — | US | disclosed |
| EP-4595973-A1 | CYCLIC PEPTIDE DERIVATIVE COMPOSITION FOR TREATING OR PREVENTING EYE DISEASE | DKS Co. Ltd. (JP) | 2025-08-06 | — | — | EP | disclosed |
| EP-4587037-A1 | BACTERIAL STRAINS FROM CLOSTRIDIA OR BACILLI AND METHODS OF TREATING OBESITY, METABOLIC SYNDROME, DIABETES AND INFLAMMATORY BOWEL DISEASE | University of Utah Research Foundation (US) | 2025-07-23 | — | — | EP | disclosed |
| CN-120165048-A | Electrolyte additive, electrolyte and battery | 广州天赐高新材料股份有限公司 | 2025-06-17 | — | — | CN | disclosed |
| CN-119852523-A | Square lithium ion battery | 深圳新宙邦科技股份有限公司 | 2025-04-18 | — | — | CN | disclosed |
| WO-2025043142-A1 | COMPOSITIONS COMPRISING LACTOBACILLUS STRAINS, AND METHODS OF TREATING OSTEOARTHRITIS AND OSTEOARTHRITIS CO-MORBIDITIES | THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS (US) | 2025-02-27 | — | — | WO | disclosed |
| US-4256108-A | Microporous-semipermeable laminated osmotic system | ALZA CORPORATION (US) | 1981-03-17 | — | — | US | disclosed |
| US-4201809-A | FATTY ACID ESTERS OF PENTAERYTHRITOL OR TRIMETHYLOLALKANE AS LUBRICANTS | FUJI PHOTO FILM CO., LTD. (JP) | 1980-05-06 | — | — | US | disclosed |
| US-4190580-A | Optically active maytansinoids and maytansinoid production method | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1980-02-26 | — | — | US | disclosed |
| US-4160452-A | Osmotic system having laminated wall comprising semipermeable lamina and microporous lamina | ALZA CORPORATION (US) | 1979-07-10 | — | — | US | disclosed |
| US-4137230-A | ESTERIFICATION IN PRESENCE OF A CARBODIIMIDE | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1979-01-30 | — | — | US | disclosed |
| US-4004976-A | CELLULASE, HEMICELLULASE, B-GLUCOSIDASE | DEUTSCHE GOLD- UND SILBER-SCHEIDEANSTALT VORMALS ROESSLER (DT) | 1977-01-25 | — | — | US | disclosed |
| US-3956491-A | ANTIULCER AGENTS | DEUTSCHE GOLD- UND SILBER-SCHEIDEANSTALT VORMALS ROESSLER (DT) | 1976-05-11 | — | — | US | disclosed |
| US-3956344-A | Process for the production of substituted 2-benzoylpyridines | DEUTSCHE GOLD- UND SILBER-SCHEIDEANSTALT VORMALS ROESSLER (DT) | 1976-05-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12567576-B2 | Method of preparing negative electrode | CACNA2D1, CACNA2D2, CACNA2D4 | ALDH1A1 3253/4885LMNA 75/4885HSD17B10 2593/4885 |
| US-20260014213-A1 | BACTERIAL STRAINS FROM CLOSTRIDIA OR BACILLI AND METHODS OF TREATING OBESITY, METABOLIC SYNDROME, DIABETES AND INFLAMMATORY BOWEL DISEASE | FABP2, SLC10A2, MSR1 | ALDH1A1 3046/4885LMNA 2471/4885HSD17B10 789/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.